T. Strowitzki

ORCID: 0000-0002-7024-855X · 32 papers in corpus · active 1991-2025

Study types

  • article 25
  • review 4
  • book-chapter 1
  • other 1
  • rct 1

Condition tags

  • endometriosis 18
  • mesh:D004715 8
  • die_deep_infiltrating 6
  • mesh:D017699 4
  • infertility 4
  • adenomyosis 2
  • mesh:D004412 1
article 2025
·doi:10.1093/humrep/deaf097.081

Abstract Study question What are the metabolome differences between the serum of patients with endometriosis and control subjects? What metabolic traits are characteristic of peritoneal and/or ovarian endometriosis? Summary answer Endometri…

other 2024
Archives of gynecology and obstetrics ·doi:10.1007/s00404-024-07516-z

PURPOSE: Endometriosis and infertility are associated with impaired partnership and sexuality of the patients, but also of their male partners. Also, endometriosis is one of the most common causes of infertility, resulting in a large overla…

article 2023
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01083-9

BACKGROUND: The pathogenesis of deep infiltrating endometriosis (DIE) is poorly understood. It is considered a benign disease but has histologic features of malignancy, such as local invasion or gene mutations. Moreover, it is not clear whe…

article 2023
·doi:10.1093/humrep/dead093.683

Abstract Study question How does the gene expression profile of epithelium cells differ between deep infiltrating endometriosis (DIE) and adenomyosis (FA)? Summary answer The gene expression of epithelial cells from DIE reveals a significan…

article 2021
·doi:10.1007/s10304-021-00385-8
article 2020
·doi:10.1007/s00129-020-04632-0
article 2020
·doi:10.1055/s-0040-1717678

Zielsetzung 10-15 % aller Frauen im reproduktiven Alter sind von Endometriose betroffen. Dennoch sind die molekularen Mechanismen sowie die Pathogenese nicht vollständig geklärt. Das Ziel der Studie war, die unterschiedlichen Stadien der Er…

article 2017
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719117741373
article 2014
·doi:10.1007/s00129-013-3283-y
article 2013
·doi:10.1093/humrep/det211

Study question: To compare the pregnancy rate in patients submitted to FET (Frozen Embryos Transfer) of cleavage stage embryos (Group 1), or at the blastocyst stage (Group 2). Summary answer: Our data showed that the transfer of frozen blas…

review 2013
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz ·doi:10.1007/s00103-013-1851-x

BACKGROUND: The incidence of female infertility has not changed since the early 1990s. Based on new data from basic research on infertility, novel options in the diagnostics and treatment of infertility have emerged, besides in vitro fertil…

article 2013
·doi:10.1007/s10304-012-0526-2
article 2012
International Journal of Gynecology & Obstetrics ·doi:10.1016/j.ijgo.2012.01.009

OBJECTIVE: To analyze the secondary efficacy and safety outcomes from a recent trial comparing dienogest (DNG) with leuprolide acetate (LA) in women with endometriosis. METHODS: A 24-week, open-label, randomized, multicenter study of DNG ve…

article 2012
·doi:10.1093/humrep/27.s2.78
review 2011
·doi:10.1016/j.jri.2011.05.002
article 2011
·doi:10.1093/humrep/26.s1.80
article 2011
Archives of gynecology and obstetrics ·doi:10.1007/s00404-011-1941-7

PURPOSE: To investigate the efficacy and safety of dienogest as a long-term treatment in endometriosis, with follow-up after treatment discontinuation. The study included women with endometriosis, who had previously completed a 12-week, pla…

article 2010
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2010.04.002
rct 2010
Human Reproduction ·doi:10.1093/humrep/dep469

BACKGROUND: Dienogest is a selective progestin that has been investigated in a clinical trial programme for the treatment of endometriosis. The current non-inferiority trial compared the efficacy and safety of dienogest against leuprolide a…

article 2010
·doi:10.1007/s00129-010-2586-5
article 2010
·doi:10.1007/s00129-010-2590-9
review 2009
Gynakologisch-geburtshilfliche Rundschau ·doi:10.1159/000197905

Die Implantation ist ein bisher nicht vollständig verstandener Prozess, der zellbiologisch ein Paradoxon darstellt. Zum einen ist der Embryo zu 50% paternal und somit teilweise immunologisch fremd, und zum anderen sind das Endometrium und d…

article 2009
·doi:10.1016/s0020-7292(09)60673-1
article 2009
·doi:10.1016/s0020-7292(09)61208-x
article 2009
·doi:10.1016/j.fertnstert.2009.07.1085